Wordt geladen...
Glycoengineering of antibody (Herceptin) through yeast expression and in vitro enzymatic glycosylation
Monoclonal antibodies (mAbs) have been developed as therapeutics, especially for the treatment of cancer, inflammation, and infectious diseases. Because the glycosylation of mAbs in the Fc region influences their interaction with effector cells that kill antibody-targeted cells, and the current meth...
Bewaard in:
| Gepubliceerd in: | Proc Natl Acad Sci U S A |
|---|---|
| Hoofdauteurs: | , , , , , |
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
National Academy of Sciences
2018
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5789950/ https://ncbi.nlm.nih.gov/pubmed/29311294 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1073/pnas.1718172115 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|